Prostate Cancer Screening

More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update th...

Full description

Saved in:
Bibliographic Details
Main Author: Ankerst, Donna Pauler
Corporate Author: SpringerLink (Online service)
Other Authors: Tangen, Catherine M., Thompson, Ian M.
Format: Electronic eBook
Language:English
Published: Totowa, NJ : Humana Press, 2009.
Edition:Second Edition.
Series:Current clinical urology.
Subjects:
Online Access:Full text (Wentworth users only).

MARC

LEADER 00000cam a22000005i 4500
001 5fb811e1-c5ca-4687-8839-2a0f74a6d4af
005 20240722000000.0
008 100301s2009 xxu| s |||| 0|eng d
020 |a 9781603272810  |9 978-1-60327-281-0 
024 7 |a 10.1007/978-1-60327-281-0  |2 doi 
035 |a (DE-He213)978-1-60327-281-0 
040 |d UtOrBLW 
049 |a WENN 
050 4 |a RC870-923.2 
050 4 |a RC875-899.5 
072 7 |a MJS  |2 bicssc 
072 7 |a MED088000  |2 bisacsh 
082 0 4 |a 616.6  |2 23 
100 1 |a Ankerst, Donna Pauler.  |0 n 2006180656 
245 1 0 |a Prostate Cancer Screening  |h [electronic resource] /  |c edited by Donna P. Ankerst, Catherine M. Tangen, Ian M. Thompson. 
250 |a Second Edition. 
264 1 |a Totowa, NJ :  |b Humana Press,  |c 2009. 
300 |b digital. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Current Clinical Urology 
520 |a More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer. 
650 0 |a Medicine.  |0 sh 85083064  
650 0 |a Medical records  |x Data processing.  |0 sh 85083013  
650 0 |a Urology.  |0 sh 85141451  
650 0 |a Epidemiology.  |0 sh 85044373  
700 1 |a Tangen, Catherine M.  |0 nb2009008684 
700 1 |a Thompson, Ian M. 
710 2 |a SpringerLink (Online service)  |0 no2005046756 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781603272803 
830 0 |a Current clinical urology.  |0 n 99801681  
856 4 0 |t 0  |u https://ezproxywit.flo.org/login?qurl=https://dx.doi.org/10.1007/978-1-60327-281-0  |y Full text (Wentworth users only). 
999 1 0 |i 5fb811e1-c5ca-4687-8839-2a0f74a6d4af  |l w1362898  |s US-MBWI  |m prostate_cancer_screening_____________________________________________elect2009____2__humana________________________________________ankerst__donna_paule_______________e 
999 1 1 |l w1362898  |s ISIL:US-MBWI  |i Wentworth  |t BKS  |a Ebooks  |c Springer  |d Other scheme  |p UNLOANABLE